Method of detecting malignancy of nasopharyngeal carcinoma and a nasopharyngeal carcinoma malignancy biomarker

• 1. 鼻咽癌相关的miRNA作为生物标志物的应用及鼻咽癌检测试剂盒 [P] . 中国专利： CN107475388B . 2020.05.19
• 2. 鼻咽癌相关的miRNA作为生物标志物的应用及鼻咽癌检测试剂盒 [P] . 中国专利： CN107475388A . 2017-12-15
• 3. METHOD OF DETECTING MALIGNANCY OF NASOPHARYNGEAL CARCINOMA AND A NASOPHARYNGEAL CARCINOMA MALIGNANCY BIOMARKER [P] . 美国专利： US2011104657A1 . 2011-05-05

  机译： 检测鼻咽癌的恶性程度的方法和鼻咽癌的恶性生物标志物

• 4. Method of Detecting Malignancy of Nasopharyngeal Carcinoma and A Nasopharyngeal Carcinoma Malignancy Biomarker [P] . 美国专利： US2011105723A1 . 2011-05-05

  机译： 鼻咽癌的恶性检测方法及鼻咽癌的生物标志物

• 5. Diagnosis of nasopharyngeal carcinoma and suppression of nasopharyngeal carcinoma invasion [P] . 美国专利： US2010003257A1 . 2010-01-07

  机译： 鼻咽癌的诊断和鼻咽癌侵袭的抑制

• 1. LMP2A, AnnexinA2, Rad52 and Gli1 expression in nasopharyngeal carcinoma and their correlation with tumor malignancy [J] . 海南医科大学学报（英文版） . 2017,第014期
• 2. LMP2A, AnnexinA2, Rad52 and Gli1 expression in nasopharyngeal carcinoma and their correlation with tumor malignancy [J] . Bin Xu, Ying Cai, Qi-Bin Song 海南医科大学学报(英文版) . 2017,第014期
• 3. Detecting plasma Epstein-Barr virus DNA to diagnose postradiation nasopharyngeal skull base lesions in nasopharyngeal carcinoma patients: a prospective study [J] . Fa-Ya Liang, Wei Sun, Ping Han, 癌症（英文版） . 2012,第003期
• 4. Expression of mir-34c-5p and mir-150-5p in nasopharyngeal carcinoma and up-regulated expression after invasion and apoptosis of nasopharyngeal carcinoma cells [J] . Xiaojun Zhou, Baorui Lin, Yun Wang 中德临床肿瘤学杂志（英文版） . 2021,第001期
• 5. Epstein-Barr virus-encoded LMP2A stimulates migration of nasopharyngeal carcinoma cells via the EGFR/Ca2+/calpain/ITG???24 axis Epstein-Barr virus-encoded LMP2A stimulates migration of nasopharyngeal carcinoma cells via the EGFR/Ca2+/calpain/ITG???24 axis Epstein-Barr virus-encoded LMP2A stimulates migration of nasopharyngeal carcinoma cells via the EGFR/Ca2+/calpain/ITG???24 axis [J] . Shixing Zheng, Ingemar Ernberg, Xiaoying Zhou, Biology Open . 2017,第6期
• 6. Comparison of Radiation-Induced Secondary Malignancy Risk Between Sequential and Simultaneous Integrated Boost for the Treatment of Nasopharyngeal Carcinoma: Intensity-Modulated Radiotherapy versus Volumetric-Modulated Arc Therapy [J] . Emel Haciislamoglu, Yunus Cinar, Mehmet Eren, Cancer Management and Research . 2020,第4期
• 7. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo [J] . Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie . 2020,第期
• 8. Constructing Novel Prognostic Biomarkers of Advanced Nasopharyngeal Carcinoma from Multiparametric MRI Radiomics Using Ensemble-Model Based Iterative Feature Selection [C] . Ting-ting Yu, Sai-kit Lam, Lok-hang To, International Conference on Medical Imaging Physics and Engineering . 2019
• 9. Novel Therapeutic Approaches and Biomarkers for Nasopharyngeal Carcinoma. [D] . Ma, Buig Yue Brigette. 2014
• 10. Comparison of Radiation-Induced Secondary Malignancy Risk Between Sequential and Simultaneous Integrated Boost for the Treatment of Nasopharyngeal Carcinoma: Intensity-Modulated Radiotherapy versus Volumetric-Modulated Arc Therapy [O] . Emel Haciislamoglu, Yunus Cinar, Mehmet Eren, 2020
• 11. Small cell neuroendocrine carcinoma: A rare second primary malignancy after treatment of nasopharyngeal carcinoma [O] . Krishnamoorthy Madhusudhan, Nor Eyzawiah binti Hassan, Norasnieda binti Md Shukri, 2018

• 1. A Case Report of Double Malignancy—Recurrent Nasopharyngeal Carcinoma and Adenocarcinoma of the Uterus [J] . Ihab E Ali ,Farid Razali ,Sobani Din . 耳鼻喉（英文） . 2019,第6期
• 2. 鼻咽癌放疗后诱发恶性肿瘤85例临床分析 [C] . 马代远 ,王仁生 . 第八届全国鼻咽癌学术会议 . 2007
• 3. ECRG4在鼻咽癌组织中的表达及其在鼻咽癌恶性生物学行为中作用与机制的研究 [A] . 臧艳姿 . 2017